← Back to Search

transcutaneous cardiac pacing for Slow Heart Rate

N/A
Waitlist Available
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one minute
Awards & highlights

Study Summary

This study is evaluating whether the placement of a pacemaker has an impact on the outcome of a patient.

Eligible Conditions
  • Slow Heart Rate

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one minute
This trial's timeline: 3 weeks for screening, Varies for treatment, and one minute for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
cardiac capture mA

Trial Design

2Treatment groups
Experimental Treatment
Group I: A-PExperimental Treatment1 Intervention
Anterior - Posterior pad placement
Group II: A-LExperimental Treatment1 Intervention
Anterior - Lateral pad placement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcutaneous cardiac pacing
2019
N/A
~20

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
687 Previous Clinical Trials
374,626 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Ideal Pacer Pad Position Study
Siamak Moayedi, MD 2019. "Ideal Pacer Pad Position Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03898050.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top